• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.

作者信息

Pontali Emanuele, D'Ambrosio Lia, Centis Rosella, Sotgiu Giovanni, Migliori Giovanni Battista

机构信息

Dept of Infectious Diseases, Galliera Hospital, Genoa, Italy.

World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Care and Research Institute, IRCCS, Tradate, Italy.

出版信息

Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.00146-2017. Print 2017 Mar.

DOI:10.1183/13993003.00146-2017
PMID:28331046
Abstract
摘要

相似文献

1
Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.耐多药结核病及其他情况：关于贝达喹啉现有证据的最新分析
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.00146-2017. Print 2017 Mar.
2
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.耐贝达喹啉结核病：地平线上的乌云。
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE.
3
New World Health Organization Treatment Recommendations for Multidrug-Resistant Tuberculosis: Are We Well Enough Prepared?世界卫生组织关于耐多药结核病的新治疗建议：我们准备得够充分吗？
Am J Respir Crit Care Med. 2019 Aug 15;200(4):514-515. doi: 10.1164/rccm.201902-0260LE.
4
Multidrug-resistant tuberculosis and bedaquiline.耐多药结核病与贝达喹啉
N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235.
5
Multidrug-resistant tuberculosis and bedaquiline.耐多药结核病与贝达喹啉
N Engl J Med. 2014 Dec 18;371(25):2436. doi: 10.1056/NEJMc1412235.
6
Current issues with the use of bedaquiline.使用贝达喹啉的当前问题。
Ann Pharmacother. 2014 May;48(5):666. doi: 10.1177/1060028014521589. Epub 2014 Feb 11.
7
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.贝达喹啉在儿童和青少年耐多药结核病中的超说明书使用。
Emerg Infect Dis. 2017 Oct;23(10):1711-3. doi: 10.3201/eid2310.170303. Epub 2017 Oct 17.
8
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?贝达喹啉在治疗耐多药结核病方面与氟喹诺酮类药物一样有效吗？
Eur Respir J. 2016 Aug;48(2):582-5. doi: 10.1183/13993003.00411-2016. Epub 2016 Jun 23.
9
Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.贝达喹啉：一种用于治疗耐多药结核病的新型抗结核药物。
Pharmacotherapy. 2014 Nov;34(11):1187-97. doi: 10.1002/phar.1482. Epub 2014 Sep 9.
10
The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report.使用贝达喹啉治疗耐多药结核病和终末期肾病患者：一例报告。
Int J Infect Dis. 2018 Nov;76:88-90. doi: 10.1016/j.ijid.2018.09.009. Epub 2018 Sep 19.

引用本文的文献

1
A Systematic Literature Review of Mathematical Models for Coinfections: Tuberculosis, Malaria, and HIV/AIDS.合并感染的数学模型系统文献综述：结核病、疟疾和艾滋病毒/艾滋病
J Multidiscip Healthc. 2024 Mar 13;17:1091-1109. doi: 10.2147/JMDH.S446508. eCollection 2024.
2
The profile of genome-wide DNA methylation, transcriptome, and proteome in streptomycin-resistant Mycobacterium tuberculosis.结核分枝杆菌链霉素耐药株全基因组 DNA 甲基化、转录组和蛋白质组特征。
PLoS One. 2024 Jan 29;19(1):e0297477. doi: 10.1371/journal.pone.0297477. eCollection 2024.
3
Efficacy of Tuberculosis Treatment in Patients with Drug-Resistant Tuberculosis with the Use of Bedaquiline: The Experience of the Russian Federation.
使用贝达喹啉治疗耐多药结核病患者的疗效：俄罗斯联邦的经验
Antibiotics (Basel). 2022 Nov 14;11(11):1622. doi: 10.3390/antibiotics11111622.
4
TB management in the European Union/European Economic Area: a multi-centre survey.欧盟/欧洲经济区的结核病管理：一项多中心调查。
Int J Tuberc Lung Dis. 2021 Feb 1;25(2):126-133. doi: 10.5588/ijtld.20.0849.
5
Challenge to treat pre-extensively drug-resistant tuberculosis in a low-income country: A report of 12 cases.低收入国家治疗广泛耐药前结核病面临的挑战：12例报告
J Clin Tuberc Other Mycobact Dis. 2020 Sep 22;21:100192. doi: 10.1016/j.jctube.2020.100192. eCollection 2020 Dec.
6
Integrated Quantitative Proteomics and Metabolome Profiling Reveal MSMEG_6171 Overexpression Perturbing Lipid Metabolism of Leading to Increased Vancomycin Resistance.整合定量蛋白质组学和代谢组学分析揭示MSMEG_6171过表达扰乱脂质代谢导致万古霉素耐药性增加。
Front Microbiol. 2020 Jul 24;11:1572. doi: 10.3389/fmicb.2020.01572. eCollection 2020.
7
What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen-presenting cell function in the lower respiratory tract.气道黏膜屏障之下隐藏着什么？聚焦下呼吸道中的抗原呈递细胞功能。
Clin Transl Immunology. 2020 Jul 23;9(7):e1158. doi: 10.1002/cti2.1158. eCollection 2020.
8
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.耐药结核病治疗。美国胸科学会/美国疾病控制与预防中心/欧洲呼吸学会/美国感染病学会临床实践指南。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.
9
Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.贝达喹啉治疗美国耐多药结核病。
Clin Infect Dis. 2020 Aug 14;71(4):1010-1016. doi: 10.1093/cid/ciz914.
10
Tuberculosis elimination: where are we now?结核病消除：我们现在在哪里？
Eur Respir Rev. 2018 Jun 13;27(148). doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30.